|
|
Measurement and analysis of Betatrophin level in cord blood of macrosomia |
ZHENG Junhu, PAN Yicong, KE Rushu, CHEN Hong, HU Xiaona, WANG Dahua |
Department of Neonatoloty, Maternal and Child Branch of Rui’an People’s Hospital, Wenzhou 325200, China |
|
Cite this article: |
ZHENG Junhu,PAN Yicong,KE Rushu, et al. Measurement and analysis of Betatrophin level in cord blood of macrosomia[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(2): 113-116.
|
|
Abstract Objective: To investigate the 1evel of cord serum Betatrophin and its clinical significance in macrosomia. Methods: A cross-sectional study was conducted. Totally 30 macrosomias and 30 normal birth weight (NBW) infants were enrolled in the study. Puerpera and cord serum Betatrophin was determined.The correlation between cord serum Betatrophin and indexes of macrosomia development, lipid metabolic parameters and serum adiponectin were analyzed. Results: The serum Betatrophin in cord blood of macrosomia (1 088.338±67.749 ng/L) was significantly higher than that of in NBW (929.487±80.949 ng/L) (t=8.242, P<0.001). The blood fat showed no statistical difference between the two groups (P>0.05). According to Pearson correlation analysis, the serum Betatrophin level in cord blood had positive correlations with birth weight, lengh, ponderal index (PI) of neonates and triglyceride (TG) in cord blood (r=0.894, 0.632, 0.860, 0.767, P<0.001). There was negative correlation between serum betatrophin and adiponectin level in cord blood (r=-0.398, P<0.05). The serum Betatrophha level in cord blood was not correlated with Betatrophin in maternal blood, body mass before pregnancy and delivery, pre-pregnancy BMI or BMI increase during pregnancy (P>0.05). Conclusion: Alteration in serum Betatrophin is correlated with macrosomia. The Betatrophin level can reflect the status of feta1 development.
|
|
|
|
|
|
[1] GUARIGUATA L, LINNENKAMP U, BEAGLEY J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy[J]. Diabetes Res Clin Pract, 2014, 103(2): 176-185.
[2] LIAO S, MEI J, SONG W, et al. The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women[J]. Diabet Med, 2014, 31(3): 341-351.
[3] KAAJA R, RöNNEMAA T. Gestational diabetes: pathogenesis and consequences to mother and offspring[J]. Rev Diabet Stud, 2008, 5(4): 194-202.
[4] YI P, PARK J S, MELTON D A. Retraction Notice to: Betatrophin: a hormone that controls pancreatic β cell prolifer-ation[J]. Cell, 2017, 168(1-2): 326.
[5] ABUFARHA M, SRIRAMAN D, CHERIAN P, et al. Circulating ANGPTL8/Betatrophin is increased in obesity and reduced after exercise training[J]. PLoS One, 2016, 11(1): e0147367.
[6] CHEN C C, SUSANTO H, CHUANG W H, et al. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function[J].Cardiovasc Diabetol, 2016, 15: 3.
[7] REN Z. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels[J]. Biochem Biophys Res Commun, 2012, 424(4): 786-792.
[8] 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 人民卫生出版社, 2011: 46-47.
[9] 诸天军. 血脂测定标准化[J]. 当代医学, 2009, 15(19): 106-107.
[10] WU S, GAO H, MA Y, et al. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance[J]. Pediatri Diabetes, 2016, 17(1): 53-60.
[11] TREBOTIC L K, KLIMEK P, THOMAS A, et al. Circulating Betatrophin is strongly increased in pregnancy and gestational diabetes mellitus[J]. Plos One, 2015, 10(9): e0136701.
[12] EMMENEGGER U, SCHAER D J, LARROCHE C, et al. Haemophagocytic syndromes in adults: current concepts and challenges ahead[J]. Swiss Med Wkly, 2005, 135(21-22): 299-314.
[13] 郑俊虎, 宋春梅, 郑骆颖, 等. 大于胎龄儿脐血脂联素水平测定及意义[J]. 中国公共卫生, 2007, 23(6): 672-674.
[14] WAWRUSIEWICZKURYLONEK N, TELEJKO B, KUZMICKI M, et al. Increased maternal and cord blood betatrophin in gestational diabetes[J]. Plos One, 2015, 10(6): e0131171. |
|
|
|